JP2018528928A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528928A5
JP2018528928A5 JP2017567608A JP2017567608A JP2018528928A5 JP 2018528928 A5 JP2018528928 A5 JP 2018528928A5 JP 2017567608 A JP2017567608 A JP 2017567608A JP 2017567608 A JP2017567608 A JP 2017567608A JP 2018528928 A5 JP2018528928 A5 JP 2018528928A5
Authority
JP
Japan
Prior art keywords
formula
compound
crystalline form
side chain
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017567608A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018528928A (ja
JP6801835B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/066281 external-priority patent/WO2017005902A1/en
Publication of JP2018528928A publication Critical patent/JP2018528928A/ja
Publication of JP2018528928A5 publication Critical patent/JP2018528928A5/ja
Application granted granted Critical
Publication of JP6801835B2 publication Critical patent/JP6801835B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017567608A 2015-07-09 2016-07-08 β−ターンペプチド模倣環状塩の液相合成及び結晶化 Active JP6801835B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562190596P 2015-07-09 2015-07-09
US62/190,596 2015-07-09
PCT/EP2016/066281 WO2017005902A1 (en) 2015-07-09 2016-07-08 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts

Publications (3)

Publication Number Publication Date
JP2018528928A JP2018528928A (ja) 2018-10-04
JP2018528928A5 true JP2018528928A5 (https=) 2019-04-18
JP6801835B2 JP6801835B2 (ja) 2020-12-16

Family

ID=56413639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017567608A Active JP6801835B2 (ja) 2015-07-09 2016-07-08 β−ターンペプチド模倣環状塩の液相合成及び結晶化

Country Status (8)

Country Link
US (4) US10125165B2 (https=)
EP (2) EP4549450A3 (https=)
JP (1) JP6801835B2 (https=)
KR (1) KR102056257B1 (https=)
CN (2) CN107849089B (https=)
AU (1) AU2016290654C1 (https=)
TW (1) TWI708779B (https=)
WO (1) WO2017005902A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6801835B2 (ja) * 2015-07-09 2020-12-16 ミメトゲン ファーマシュウティカルズ インコーポレイテッドＭｉｍｅｔｏｇｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． β−ターンペプチド模倣環状塩の液相合成及び結晶化
EP4067368A1 (en) 2016-06-01 2022-10-05 Athira Pharma, Inc. Compounds
CA3098707A1 (en) * 2018-05-31 2019-12-05 Gap Peptides Llc Method for solution-phase peptide synthesis and protecting strategies thereof
US11427612B2 (en) * 2018-08-21 2022-08-30 Wayne State University Epimerization-free N to C solid-phase peptide synthesis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP254898A0 (en) * 1998-03-24 1998-04-23 University Of Queensland, The Peptide turn mimetics
DE60123399T2 (de) 2000-01-18 2007-08-23 The Texas A & M University System, College Station Pharmazeutische zubereitungen enthaltend beta-turn peptidomimetische zyklische substanzen
EP1517915B1 (en) * 2002-06-11 2009-01-21 Eli Lilly And Company Prodrugs of excitatory amino acids
WO2009123761A1 (en) * 2008-04-04 2009-10-08 Mimetogen Pharmaceuticals Inc. Beta-turn peptidomimetic cyclic compounds for treating dry eye
EP2400977B1 (en) * 2009-02-27 2014-07-23 Mimetogen Pharmaceuticals Inc. Peptidomimetic cyclic compounds for treating retinitis pigmentosa
WO2012013281A1 (de) * 2010-07-29 2012-02-02 Merck Patent Gmbh Flüssigkristallines medium enthaltend thiophenderivate
JP5710436B2 (ja) * 2011-09-26 2015-04-30 株式会社東芝 パターン形成方法
EP2864347B1 (en) * 2012-06-22 2020-10-28 Mimetogen Pharmaceuticals, Inc. Synthesis of beta-turn peptidomimetic cyclic compounds
JP6516974B2 (ja) * 2013-06-14 2019-05-22 豊田合成株式会社 ゴム組成物及びゴム製品
WO2014204681A1 (en) * 2013-06-20 2014-12-24 Exxonmobil Chemical Patents Inc. Long-bridged salen catalyst
JP6801835B2 (ja) * 2015-07-09 2020-12-16 ミメトゲン ファーマシュウティカルズ インコーポレイテッドＭｉｍｅｔｏｇｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． β−ターンペプチド模倣環状塩の液相合成及び結晶化

Similar Documents

Publication Publication Date Title
KR101934096B1 (ko) 이델라리십의 제조방법
CN111386272B (zh) 一种改进的瑞博西尼及其盐的制备方法
WO2020095983A1 (ja) Ｏ－置換セリン誘導体の製造方法
CA3080138A1 (en) Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
CN112574196A (zh) 调节激酶的1H-吡咯并[2,3-b]吡啶衍生物的合成
CN107964016A (zh) 噻吩衍生物
RS65437B1 (sr) (r) i (s) enantiomeri n-(5-(3-hidroksipirolidin-1-il)-2-morfolinooksazolo[4,5-b]piridin-6-il)-2-(2-metilpiridin-4-il)oksazol-karboksamida kao inhibitori irak4 za lečenje kancera
US9440981B2 (en) Pyrrolo[2, 1-F] [1,2,4]triazine derivative and use thereof for treating tumors
JP2018528928A5 (https=)
CN108699063A (zh) 一种芦可替尼的合成工艺
US20200361944A1 (en) Fragment synthesis of cyclic peptides
CN104470913B (zh) 用于制造羟基化的环戊基嘧啶化合物的方法
AU2013302473A1 (en) Pyrrolopyrazoles as N-type calcium channel blockers
JP7384963B2 (ja) ３，６－ジ置換イミダゾ［１，２－ｂ］ピリダジン誘導体の製造方法
WO2018137679A1 (en) Process for the Preparation of (10R) -7- (2-aminoacetyl) amino-12-fluoro-2, 10, 16-trimethyl-15-oxo-10, 15, 16, 17-tetrahydro-2H-8, 4- (metheno) pyrazolo [4, 3-h] [2, 5, 11] -benzoxadiazacyclotetradecine-3-carbonitrile
JP4208463B2 (ja) キノロンカルボン酸誘導体の製造に関する中間体
KR20200109314A (ko) 아미노-피리미딘 및 이의 중간체의 제조 공정
WO2008139481A2 (en) Proton acceptor iminium/carbocation-type coupling agents
JP7235718B2 (ja) モノバクタム系抗生物質およびその中間体を製造するための化学的方法
US6818764B2 (en) Process for preparing substance GM-95
WO2009138985A2 (en) Coupling agents for the synthesis of polypeptides and polynucleotides
CN105130997B (zh) 一种库潘尼西的制备方法
WO2011079935A2 (en) A process for the preparation and isolation of vardenafil and salts thereof
WO2017109524A1 (en) Method and intermediate for the production of baricitinib
WO2017049983A1 (zh) 库潘尼西的制备方法